Biomanufacturing has entered a phase where scientific innovation is no longer the primary constraint. The tools exist. The modalities exist. Capital exists. What increasingly limits progress is coordination. Programs stall not because biology fails, but because execution fragments. Capabilities are distributed across dozens of specialized organizations. Knowledge is siloed. Capacity is opaque. Decisions made early—often […]